InsiderTrades

Form 4 for MRK Merck & Co.

Accepted 2025-08-05 00:00:00 ET · period of report 2025-08-04 · accession 0000310158-25-000012 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2025-08-05 2025-08-04 MRK Williams David Michael EVP, Chief Info, Digital Off M - OptEx $79.29 +17.1K 41.4K +70% +$1.36M
D 2025-08-05 2025-08-04 MRK Williams David Michael EVP, Chief Info, Digital Off F - Tax $79.29 -8,432 33.0K -20% -$668.6K
D 2025-08-05 2025-08-04 MRK Williams David Michael EVP, Chief Info, Digital Off M - OptEx $0.00 -17.1K 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2025-08-04 M A 17,119 $79.29 41,445.47 D — — (F1) Holdings include shares acquired in dividend reinvestment transactions.
2 Common Common Stock 2025-08-04 F D 8,432 $79.29 33,013.47 D — —
3 Derivative Restricted Stock Unit 2025-08-04 M D 17,119 $0.00 0 D — · 2025-08-03 to 2025-08-03 17,119 Common Stock (F2) Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. (F3) These restricted stock units vested and were distributed as shares of Merck & Co., Inc. common stock in one installment on 8/4/2025, the business day immediately following 8/3/2025. The Reporting Person's Form 4 filed on 8/4/2022 incorrectly reported that these restricted stock units vested and were to be distributed in three equal installments on 8/3/2023, 8/3/2024, and 8/3/2025.